TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106. A total of 130 filers reported holding TCR2 THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.41 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $213,000 | – | 6,884 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 4,050,865 | $62,221,000 | 18.51% |
| MPM BioImpact LLC | 3,370,982 | $51,778,000 | 13.77% |
| Redmile Group, LLC | 1,765,188 | $27,113,000 | 0.50% |
| ArrowMark Colorado Holdings LLC | 1,356,010 | $20,828,000 | 0.22% |
| DAFNA Capital Management LLC | 46,183 | $709,000 | 0.20% |
| Artal Group S.A. | 350,000 | $5,376,000 | 0.15% |
| WFA of San Diego, LLC | 4,733 | $540,000 | 0.13% |
| Granite Point Capital Management, L.P. | 100,000 | $1,536,000 | 0.08% |
| HHLR ADVISORS, LTD. | 322,903 | $4,960,000 | 0.04% |
| SPHERA FUNDS MANAGEMENT LTD. | 30,000 | $461,000 | 0.04% |